位置:首页 > 蛋白库 > CDIA_ENTCC
CDIA_ENTCC
ID   CDIA_ENTCC              Reviewed;        3321 AA.
AC   D5CBA0;
DT   04-MAR-2015, integrated into UniProtKB/Swiss-Prot.
DT   15-JUN-2010, sequence version 1.
DT   25-MAY-2022, entry version 69.
DE   RecName: Full=16S rRNA endonuclease CdiA {ECO:0000305};
DE            Short=rRNase CdiA;
DE            EC=3.1.-.-;
DE   AltName: Full=CdiA-ECL;
DE   AltName: Full=Toxin CdiA;
DE   Flags: Precursor;
GN   Name=cdiA; OrderedLocusNames=ECL_04451;
OS   Enterobacter cloacae subsp. cloacae (strain ATCC 13047 / DSM 30054 / NBRC
OS   13535 / NCTC 10005 / WDCM 00083 / NCDC 279-56).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Enterobacter; Enterobacter cloacae complex.
OX   NCBI_TaxID=716541;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 13047 / DSM 30054 / NBRC 13535 / NCTC 10005 / WDCM 00083 / NCDC
RC   279-56;
RX   PubMed=20207761; DOI=10.1128/jb.00067-10;
RA   Ren Y., Ren Y., Zhou Z., Guo X., Li Y., Feng L., Wang L.;
RT   "Complete genome sequence of Enterobacter cloacae subsp. cloacae type
RT   strain ATCC 13047.";
RL   J. Bacteriol. 192:2463-2464(2010).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DOMAIN.
RC   STRAIN=ATCC 13047 / DSM 30054 / NBRC 13535 / NCTC 10005 / WDCM 00083 / NCDC
RC   279-56;
RX   PubMed=24889811; DOI=10.1111/mmi.12658;
RA   Beck C.M., Diner E.J., Kim J.J., Low D.A., Hayes C.S.;
RT   "The F pilus mediates a novel pathway of CDI toxin import.";
RL   Mol. Microbiol. 93:276-290(2014).
RN   [3]
RP   FUNCTION, REQUIRES PMF FOR TRANSLOCATION, AND SUBCELLULAR LOCATION.
RC   STRAIN=ATCC 13047 / DSM 30054 / NBRC 13535 / NCTC 10005 / WDCM 00083 / NCDC
RC   279-56;
RX   PubMed=25174572; DOI=10.1111/mmi.12779;
RA   Ruhe Z.C., Nguyen J.Y., Beck C.M., Low D.A., Hayes C.S.;
RT   "The proton-motive force is required for translocation of CDI toxins across
RT   the inner membrane of target bacteria.";
RL   Mol. Microbiol. 94:466-481(2014).
RN   [4]
RP   FUNCTION, RECEPTOR FOR ENTRY INTO TARGET CELL CYTOPLASM, AND DOMAIN.
RC   STRAIN=ATCC 13047 / DSM 30054 / NBRC 13535 / NCTC 10005 / WDCM 00083 / NCDC
RC   279-56;
RX   PubMed=26305955; DOI=10.1073/pnas.1512124112;
RA   Willett J.L., Gucinski G.C., Fatherree J.P., Low D.A., Hayes C.S.;
RT   "Contact-dependent growth inhibition toxins exploit multiple independent
RT   cell-entry pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:11341-11346(2015).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 3087-3321 IN COMPLEX WITH CDII,
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, INDUCTION, DOMAIN, AND MUTAGENESIS
RP   OF ASP-3289; ASP-3291; HIS-3293 AND LYS-3300.
RC   STRAIN=ATCC 13047 / DSM 30054 / NBRC 13535 / NCTC 10005 / WDCM 00083 / NCDC
RC   279-56;
RX   PubMed=24657090; DOI=10.1016/j.str.2014.02.012;
RA   Beck C.M., Morse R.P., Cunningham D.A., Iniguez A., Low D.A.,
RA   Goulding C.W., Hayes C.S.;
RT   "CdiA from Enterobacter cloacae delivers a toxic ribosomal RNase into
RT   target bacteria.";
RL   Structure 22:707-718(2014).
CC   -!- FUNCTION: Toxic component of a toxin-immunity protein module, which
CC       functions as a cellular contact-dependent growth inhibition (CDI)
CC       system. CDI modules allow bacteria to communicate with and inhibit the
CC       growth of closely related neighboring bacteria in a contact-dependent
CC       fashion; upon forced induction decreases E.cloacae target cell counts
CC       about 20-fold, about 100-fold in E.coli. Intracellular expression of
CC       CdiA-CT (residues 3087-3321) inhibits E.coli cell growth when induced,
CC       but coexpression with its cognate immunity protein CdiI allows cell
CC       growth. Cleaves 16S rRNA in vivo and in vitro between adenine 1493 and
CC       guanosine 1494 of E.coli 16S rRNA. Inhibition of 16S rRNA cleavage is
CC       specific to the cognate immunity protein, non-cognate CdiI from
CC       E.chrysanthemi strain EC16 does not inhibit this protein
CC       (PubMed:24657090). Purified CdiA-CT inhibits E.coli cell growth when
CC       added to cultures but not when added as a complex with cognate CdiI,
CC       suggesting cognate CdiI prevents import into the target cell. CdiA-CT
CC       (without CdiI) is probably imported in an F-pilus-mediated fashion,
CC       although it is not clear if this is physiologically significant
CC       (PubMed:24889811). Gains access to the cytoplasm of target cells by
CC       using integral inner membrane protein FtsH (PubMed:26305955).
CC       {ECO:0000269|PubMed:24657090, ECO:0000269|PubMed:24889811,
CC       ECO:0000269|PubMed:26305955}.
CC   -!- FUNCTION: The CdiA protein is thought to be exported from the cell
CC       through the central lumen of CdiB, the other half of its two-partner
CC       system (TPS). The TPS domain probably remains associated with CdiB
CC       while the FHA-1 domain forms an extended filament with the receptor-
CC       binding domain (RBD) at its extremity; in the secretion arrested state
CC       the C-terminus of the RBD and YP domains form a hairpin-like structure
CC       as the FHA-2, PT and CT domains are periplasmic. The YP domain is
CC       probably responsible for this arrest at the point where it re-enters
CC       the host cell periplasm. Upon binding to a target cell outer membrane
CC       receptor a signal is transmitted to activate secretion. The filament
CC       elongates slightly, the rest of CdiA is secreted and the FHA-2 domain
CC       becomes stably associated with the target cell's outer membrane where
CC       it facilitates entry of the toxic CT domain into the target cell
CC       periplasm. From there the toxic CT domain is cleaved and gains access
CC       to the target cell cytoplasm via an inner membrane protein (FtsH for
CC       this CDI). {ECO:0000305}.
CC   -!- SUBUNIT: Interacts with cognate immunity protein CdiI, blocking the
CC       active site of the nuclease. {ECO:0000269|PubMed:24657090}.
CC   -!- SUBCELLULAR LOCATION: Target cell, target cell cytoplasm
CC       {ECO:0000269|PubMed:24657090, ECO:0000269|PubMed:24889811,
CC       ECO:0000269|PubMed:25174572}. Note=Secreted to the cell surface by
CC       CdiB, its two partner secretion pathway (TPS) partner (Probable). Toxin
CC       translocation into the target cell depends on the proton motive force
CC       of the target cell, but not on tolA or tonB.
CC       {ECO:0000269|PubMed:25174572, ECO:0000305}.
CC   -!- INDUCTION: Not expressed under laboratory conditions.
CC       {ECO:0000269|PubMed:24657090}.
CC   -!- DOMAIN: The 16S rRNASe and CDI activities reside in the C-terminal (CT)
CC       domain, residues 3087-3321 (PubMed:24657090, PubMed:24889811). The
CC       inner membrane translocation domain (IMTD) targets the toxin to a
CC       specific target cell inner membrane protein (FtsH in this case), which
CC       delivers the toxin to the target cell cytoplasm (Probable).
CC       {ECO:0000269|PubMed:24657090, ECO:0000269|PubMed:24889811,
CC       ECO:0000305|PubMed:26305955}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the CdiA toxin
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001918; ADF63980.1; -; Genomic_DNA.
DR   RefSeq; WP_013098820.1; NC_014121.1.
DR   RefSeq; YP_003614929.1; NC_014121.1.
DR   PDB; 4NTQ; X-ray; 2.40 A; A=3087-3321.
DR   PDBsum; 4NTQ; -.
DR   SMR; D5CBA0; -.
DR   DIP; DIP-60810N; -.
DR   STRING; 716541.ECL_04451; -.
DR   EnsemblBacteria; ADF63980; ADF63980; ECL_04451.
DR   KEGG; enc:ECL_04451; -.
DR   PATRIC; fig|716541.4.peg.4605; -.
DR   eggNOG; COG3210; Bacteria.
DR   HOGENOM; CLU_000043_2_2_6; -.
DR   OMA; NVADANL; -.
DR   Proteomes; UP000002363; Chromosome.
DR   GO; GO:0030430; C:host cell cytoplasm; IDA:UniProtKB.
DR   GO; GO:0004521; F:endoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   Gene3D; 2.160.20.10; -; 1.
DR   Gene3D; 3.10.380.20; -; 1.
DR   InterPro; IPR010069; CdiA_FHA1_rpt.
DR   InterPro; IPR008619; Filamentous_hemagglutn_rpt.
DR   InterPro; IPR008638; Filamn_hemagglutn_N.
DR   InterPro; IPR025157; Hemagglutinin_rpt.
DR   InterPro; IPR028190; Ntox21.
DR   InterPro; IPR038181; Ntox21_sf.
DR   InterPro; IPR012334; Pectin_lyas_fold.
DR   InterPro; IPR011050; Pectin_lyase_fold/virulence.
DR   InterPro; IPR006914; VENN_dom.
DR   Pfam; PF05594; Fil_haemagg; 10.
DR   Pfam; PF13332; Fil_haemagg_2; 4.
DR   Pfam; PF05860; Haemagg_act; 1.
DR   Pfam; PF15526; Ntox21; 1.
DR   Pfam; PF04829; PT-VENN; 1.
DR   SMART; SM00912; Haemagg_act; 1.
DR   SUPFAM; SSF51126; SSF51126; 1.
DR   TIGRFAMs; TIGR01901; adhes_NPXG; 1.
DR   TIGRFAMs; TIGR01731; fil_hemag_20aa; 20.
PE   1: Evidence at protein level;
KW   3D-structure; Endonuclease; Hydrolase; Nuclease; Signal;
KW   Target cell cytoplasm; Toxin; Virulence.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000255"
FT   CHAIN           33..3321
FT                   /note="16S rRNA endonuclease CdiA"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000432090"
FT   REGION          37..323
FT                   /note="Two-partner system transport domain (TPS)"
FT                   /evidence="ECO:0000250|UniProtKB:Q3YL96"
FT   REGION          332..1496
FT                   /note="FHA-1"
FT                   /evidence="ECO:0000305"
FT   REGION          430..453
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1497..1802
FT                   /note="Receptor binding domain (RBD)"
FT                   /evidence="ECO:0000250|UniProtKB:A0A1S4NYE3"
FT   REGION          1788..1812
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1803..1987
FT                   /note="YP domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q3YL96"
FT   REGION          1837..1875
FT                   /note="Periplasmic FHA-1 repeat (pFR)"
FT                   /evidence="ECO:0000305"
FT   REGION          1988..2586
FT                   /note="FHA-2"
FT                   /evidence="ECO:0000305"
FT   REGION          2510..2552
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3087..3321
FT                   /note="CT domain; toxic when added to the outside of
FT                   E.coli, 16S rRNase activity"
FT                   /evidence="ECO:0000269|PubMed:24657090,
FT                   ECO:0000269|PubMed:24889811"
FT   REGION          3091..3208
FT                   /note="Inner membrane translocation domain (IMTD), targets
FT                   protein to FtsH"
FT                   /evidence="ECO:0000305|PubMed:26305955"
FT   REGION          3174..3236
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           3087..3090
FT                   /note="AENN CT cleavage motif"
FT                   /evidence="ECO:0000305"
FT   COMPBIAS        2516..2552
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        3182..3234
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         3289
FT                   /note="D->A: No CDI activity, loss of rRNase, when
FT                   expressed as isolated CT domain."
FT                   /evidence="ECO:0000269|PubMed:24657090"
FT   MUTAGEN         3291
FT                   /note="D->A: Delayed CDI activity, reduced rRNase, when
FT                   expressed as isolated CT domain."
FT                   /evidence="ECO:0000269|PubMed:24657090"
FT   MUTAGEN         3293
FT                   /note="H->A: No CDI activity, loss of rRNase, when
FT                   expressed as isolated CT domain in vitro, or in vivo as a
FT                   fusion with E.coli strain EC93 CdiA."
FT                   /evidence="ECO:0000269|PubMed:24657090"
FT   MUTAGEN         3300
FT                   /note="K->A: No CDI activity, loss of rRNase, when
FT                   expressed as isolated CT domain."
FT                   /evidence="ECO:0000269|PubMed:24657090"
FT   HELIX           3250..3256
FT                   /evidence="ECO:0007829|PDB:4NTQ"
FT   TURN            3257..3259
FT                   /evidence="ECO:0007829|PDB:4NTQ"
FT   STRAND          3262..3264
FT                   /evidence="ECO:0007829|PDB:4NTQ"
FT   STRAND          3278..3280
FT                   /evidence="ECO:0007829|PDB:4NTQ"
FT   STRAND          3285..3288
FT                   /evidence="ECO:0007829|PDB:4NTQ"
FT   TURN            3295..3297
FT                   /evidence="ECO:0007829|PDB:4NTQ"
FT   STRAND          3299..3302
FT                   /evidence="ECO:0007829|PDB:4NTQ"
FT   STRAND          3306..3312
FT                   /evidence="ECO:0007829|PDB:4NTQ"
FT   STRAND          3318..3320
FT                   /evidence="ECO:0007829|PDB:4NTQ"
SQ   SEQUENCE   3321 AA;  337829 MW;  8705245161CF8846 CRC64;
     MMKQDQVRFS QRALSALLSV LLATQPLLPA VAASITPSGN TQMDKAANGV PVVNIATPNQ
     SGISHNKYND YNVGKEGLIL NNATGQLNQT QLGGLIQNNP NLKAGQEAKG IINEVTGANR
     SNLQGYTEVA GKAANVIVAN PYGITCNGCG FINTPNVTLT TGKPVLDASG KLQSLDVTQG
     AVTIEGAGLN GSQSDAVSII SRATEINVQL HAKDLRVVAG ANRVAADGSV SALKGEGTAP
     KVAVDTGALG GMYANRIRLV SSETGVGVNL GNLNARQGDI ALSSAGKVVL KNTLASGSTT
     VSAADVTLRG DHKAGGNVTV SGQTALTLDQ AHVAADNNLQ LTTRGTLTQN GGAFTAANDA
     TLAATTLIQS VDAQASAGRH LAVNAEKNAA LNGSVVAGQQ LSVKGGELVQ QGNLSASEIA
     LNAQTLTQES RSTTNASGNI TLTTSGHSQL KGSTTAGQSL AVSAGSLANH GALAAVADTR
     INTGIFSNTG TVQGNSLTVS GTDITSSGAL KSASTLDIRA DNATLSGETG AKGKTTVTAS
     GNLNNSGTLI SDDTLTLNAA QIVNSGTLSG VRGLTTSGKT FTASATSVTQ SDGDVALNNT
     DTTLAGETSA GGAVTVQGRS LNTTATAQTQ GNSVGVAVQN AKLEGTQAAK GNMTLKADSS
     LNHTGKSSAS GLKVETGHLS NSGTLTASAL VIDSPEVING GLIHAGQTLS LVTRLLDNRS
     SGVLYSPSAL SLSLSELNNA GIITSDAALS LSGSNLTNSG ELSGTSLAID YETLKNSAEG
     MLLAQGANRI TAQSVSSAGS MVGNTLTLNA DRLESAGLLQ GDSALSLTAG ILNLLTGSRT
     LTGGALGLSG TTLTTAGQLQ GQDVSIRSHD WTNRGSSLAT GSLDVTTAGT LSNTGELMSQ
     GNGTLNAVTT VNSGNMLSAG DLSLNGKTLR NSGTLQGNRV TAHQDTITNS GTLTGIAALM
     LAARLEMAAP LLTLVNDASG SLLTAGELSV TGGDLRNAGQ WQGKRVLIHA QALTNGGAIQ
     AENLLDAQID STLTGTAGSK ITSNGELALS ALTLANSGQW IAKHLTLGAS TLNNSGEITG
     VVALSVALTQ LNNQAGGKLL SAGALTLDVE NATNAGQIQG KATTVTAGQL INSGRLQGEA
     LTLNASGALN NTASGVLLSE NALTVSTATL NNQGTLQGGG ESSVKATTRV QNDGKMLSGG
     KLTLTAPELA NSSSGLVQAV RLLLDVVKAV NGGNVLATTR AELRGSSLDN SGTLQGADLQ
     ANYQSVTNSG TVLGTTSLTI NGDALDNTES GKLYSGDKLL LDVRNYSGRG DVVSLGDTTL
     KLVNALVNTG TLAASKTLSV SSQNAMTNSG VMQGNAIALS AGGAFTNNGT LTTGNGSSTF
     NAQSLLLNAS GSLQAGGDVQ LTSRENITVN GFTGTAGSLT MTAAGTLLNT ALIYAGNNIS
     LFAARIHNIY GDILADNSLW MQKNAVGEAN AEVVNRSGTI ETTRGDITVN TGHLLNEADG
     LTVSQSEREY PDAIPAADEH YFSYDLNGRR SDFVLLLEDW KNDGSKVVYD WYEQCLGSGA
     NGSGQCRDRV DYRLTGEDIR QFLLSESVVS VSATGSSARI AAGRDITINA GTLDNRASHI
     LAGRNAVLAG GTLNNLSAEG GRRVTYVQAE YRCEWFYRDC SDSKWEPLTQ YPDGSWGWFD
     EDYGWYGWVP YILGERTTEF VADGGVYRSV ISAGGNVSAN FTSDISNTNV TANSGEFSNT
     IDAPTLNTLS PEAIGKGLNS ESLAQGGSAD IRFPEQLGNI TDALKDISGG SSLSDQNGSS
     GNYPLPSGNN GYFVPSTDPD SPYLITVNPK LDELGNMDDS LFNGLYDLLG ITPGATPRET
     NSAYTDRNQF LGSSYFLDRL GLNPDRDYRF LGDAAFDTRY VSNAILNQTG SRYINGIGSD
     LDQMRYLMDS AAEQQKTLGL KFGVALTAEQ VAALDKSMLW WESATINGQT VMIPKVYLSP
     KDVTVHSGSV ISGNNVQLAG GNVINSGSTI AAQNGLSIDS SNSLSNLNAG LLSAGGGLNL
     SALGDINNIG STISGKTVGL ESVAGSINNI TRAQQWNVDA GNVHFSGTDV GKTASITATD
     GLTMRAGQDI NVTGANVSAG GSLGMAAGND INITANEIVT SEGRAGRNRA TTETASVTHQ
     GSTLSAGDDL TLQAGNDVNA RAAAIAAEGD VGIQAGRDVD LLAEASMERS SSQAKKKTAI
     DESVRQQGTE IASGGNTVIL AGRDVTAQAA DVTAQGDIGV AAGRDVNLTT ATESDYRYRE
     QTKTSSGFLS KKTTHTIEEE SATREKGSLL SGDNVTVSAG NNLRVLGSAV AGDGDVALSA
     GNNVDIVAAT NTDTAWRFKE TKKSGLMGTG GIGFTIGSSK STHDLREQGT TQSESFSTVG
     STGGNVSIAA GKQAHIGGAD IIAQKDISLT GDSVVIEPGH DKRTRDEKFE QKSSGLTVAL
     SGAAGSAVNN AVTTAQSAKQ SSDSRLAALQ GTQAALSGVQ AGQAVALDQV KGDSDKRNNN
     TIGVSASIGS QSSKSSSHME SETTTGSTLS AGNNVTIKAT GSDITVAGSQ IKAGKDVTLD
     AARDVNLIAS QDTQQTTGKN SSSGGSLGVG VGVGSGGAGI SISANANSSK GHEKGNGVWQ
     NETTVDAGNR VTINTGRDAT IAGAQVSGET VVADIGRDLT IASTQDSDHY NSKQNSVSGG
     AGYTFGAGGF SGSINVSRDK MTSDYDSVQE QSGLFAGNGG FDVTVGNHTQ LDSGVIASTA
     TADKNRLDTG TLGFSDIHNQ ADFKTEHQGA GISSGGSIGK QFAGNMANAL LAGGGNSGHA
     EGTTQAAVSE GTLIIRDKEN QKQDVADLSR DAEHANGSIS PIFDKEKEQQ RLQEVQLIGE
     IGSQVVDIAN TQGEINGLNA GRKELADKGI TEPGADASDE VKAAYQNALR ETDAYKTTTA
     KYGTGSDLQR GIQAATAALQ GLAGSDLTAA LAGASAPELA YRIGHGMGID NNTAAKTIAH
     AILGGAVAAL QGNSAAAGAA GAATGELAAK AIAGMLYPDV KDLSTLSEEQ KQTVSALATI
     SAGMAGGLAG DSTGSAVAGG QAGKNAAENN SLALVARGCA VAAPCRTKVA EQLLEIGAKA
     GIAGLAGAAV KDMADKMTSD ELEHLVTLEM MGNDEIIAKY VSLLHDKYAP SHTGGNLLPE
     TLPGHTGNNT GSVDTGPNHT GNTNRQNDSG SNNTGNTEGA PNTGGNTTIT PIPNGPSKDD
     IAYLALKGKE AQEAASNLGF DRRIPPQKAP FNSHGQPVFY DGKNYITPDI DSHNVTNGWK
     MFNSKGKRIG TYDSGLNRIK D
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024